VIDEO: CASTLE-AF suggests atrial fibrillation burden better predicts outcomes
May 16, 2018|Cardiology News
REPORTING FROM HEART RHYTHM 2018
CASTLE-AF was sponsored by Biotronik. Dr. Brachmann has been a consultant to and has received research funding from Biotronik and several other companies. Dr. Krahn has been a consultant to Medtronic and has received research support from Medtronic and Boston Scientific. Dr. Link had no disclosures.
SOURCE: Brachmann J et al. Heart Rhythm 2018, Abstract B-LBCT02-04.
